News View all news
FDA seeks participants for track-and-trace pilot projects
FDA announced in February the launch of a pilot project program to test innovative ways for drug supply chain members to overcome barriers in the development of the enhanced electronic, interoperable “track-and-trace” system. The pilot project program seeks applications from groups of trading partners, including pharmacies, to take an active role in testing advance systems that are expected to inform how final track-and-trace systems will work as Drug Supply Chain Security Act (DSCSA) implementation progresses.
Gottlieb discusses efforts to secure U.S. drug supply chain, cites warning letter to McKesson
FDA Commissioner Scott Gottlieb discusses the agency's efforts to stop the spread of illicit opioids and further secure all aspects of the supply chain for legitimate medications, including opioids. On Tuesday, the agency announced it has issued its first warning letter under the Drug Supply Chain Security Act (DSCSA) to McKesson Corp.
Modification to clozapine REMS takes place February 28
According to a modified Risk Evaluation and Mitigation Strategy (REMS) program for clozapine, starting February 28, 2019, pharmacists are no longer allowed to enroll patients in the Clozapine REMS Program, and pharmacies must also be certified to dispense clozapine.
January 29, 2019
With pharmacists left out of medication-assisted treatment,…
Every day, more than 100 families suffer the loss of a loved one to an opioid overdose. On November 1, 2018, ours became one of them when my great-niece Chloe Archer lost her battle with opioid use…0 comments
February 5, 2019
APhA Celebrates Pharmacists’ Contributions to Increasing U.S. Immunization Rates and Improving Health
The American Pharmacists Association (APhA) today announced the selection of recipients of its 2019 Immunization Champion Awards recognizing individuals and organizations who have made extraordinary contributions toward improved vaccination rates within their communities.
February 4, 2019
APhA Issues Revised Guidelines for Pharmacy-based Immunization Advocacy and Administration
As the pharmacist role in raising the rate of immunizations continues to expand, the American Pharmacists Association (APhA) has revised its Guidelines for Pharmacy-based Immunization Advocacy and Administration. The Guidelines cover five areas of focus: Prevention, Partnership, Quality, Documentation, and Empowerment.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.